$15 BILLION CONSUMER HEALTH CARE BUSINESS ON PFIZER
Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth some $15 billion up for grabs. Read More...